Zinc, metallothioneins and immunosenescence

Proceedings of the Nutrition Society

Volumn 69, Issue 3, 2010, Pages 290-299

  Mocchegiani, E ^a   Malavolta, M ^a   Costarelli, L ^a   Giacconi, R ^a   Cipriano, C ^a   Piacenza, F ^a   Tesei, S ^a   Basso, A ^a   Pierpaoli, S ^a   Lattanzio, F ^a  

^a INRCA   (Italy)

Author keywords

Ageing; Immune response; Inflammation; Longevity; Metallothioneins; Zinc signalling; Zinc supplementation; Zinc transporters

Indexed keywords

ALPHA INTERFERON; FLUORESCENT DYE; GLYCOPROTEIN GP 130; INTERLEUKIN 1; INTERLEUKIN 6; ISOPROTEIN; MESSENGER RNA; METALLOTHIONEIN; METALLOTHIONEIN I; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; STEM CELL FACTOR; TETANUS TOXOID; THYMULIN; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ZINC; ZINC TRANSPORTER;

AGED; AGING; ANTIOXIDANT ACTIVITY; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CELL SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CYTOTOXICITY; DELAYED HYPERSENSITIVITY; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DOWN SYNDROME; FLOW CYTOMETRY; GENE EXPRESSION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HELPER CELL; HETEROZYGOTE; HOMEOSTASIS; HORMONE ACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFECTION RATE; INFLAMMATION; INNATE IMMUNITY; LONGEVITY; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SECOND MESSENGER; SENESCENCE; SIGNAL TRANSDUCTION; STRESS; THYMUS FUNCTION; ZINC BLOOD LEVEL; ZINC DEFICIENCY; ZINC METABOLISM;

AGED; AGING; CARRIER PROTEINS; DIETARY SUPPLEMENTS; GENETIC VARIATION; HUMANS; IMMUNITY; INTERLEUKIN-6; METALLOTHIONEIN; ZINC;

EID: 77957348605     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665110001862     Document Type: Conference Paper

References (70)

1. Paolisso G, Barbieri M, Bonafè M et al. (2000) Metabolic age modelling: the lesson from centenarians. Eur J Clin Invest 10, 888-894.
2. Ames BN (2006) Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci USA 103, 17589-17594.
3. Kant AK (2000) Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 72, 929-936.
4. Tucker KL & Buranapin S (2001) Nutrition and aging in developing countries. J Nutr 9, 2417S-2423S.
5. Failla ML (2003) Trace elements and host defense: recent advances and continuing challenges. J Nutr 133, Suppl. 1, 1443S-1447S.
6. Chernoff R (2001) Nutrition and health promotion in older adults. J Gerontol A Biol Sci Med Sci 56, 47-53.
7. Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12, 646-652.
8. Fraker PJ & Lill-Elghanian DA (2004) The many roles of apoptosis in immunity as modified by aging and nutritional status. J Nutr Health Aging 8, 56-63.
9. Mocchegiani E, Costarelli L, Giacconi R et al. (2006) Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mech Ageing Dev 127, 517-525.
10. Liuzzi JP & Lichten LA, Rivera S et al. (2005) Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci USA 102, 6843-6848.
11. Mocchegiani E, Muzzioli M & Giacconi R (2000) Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol Sci 21, 205-208.
12. Cousins RJ, Liuzzi JP & Lichten LA (2006) Mammalian zinc transport, trafficking, and signals. J Biol Chem 281, 24085-24089.
13. Krezel A, Hao Q & Maret W (2007) The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling. Arch Biochem Biophys 463, 188-200.
14. Sato M & Kondoh M (2002) Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med 196, 9-22.
15. Kelly EJ, Quaife CJ, Froelick GJ et al. (1996) Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J Nutr 126, 1782-1790.
16. Mocchegiani E, Giacconi R, Cipriano C et al. (2002) MTmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp Gerontol 37, 349-357.
17. Williams PD & Day T (2003) Antagonistic pleiotropy, mortality source interactions, and the evolutionary theory of senescence. Evolution Int J Org Evolution 57, 1478-1488.
18. Moroni F, Di Paolo ML, Rigo A et al. (2005) Interrelationship among neutrophil efficiency, inflammation, antioxidant activity and zinc pool in very old age. Biogerontology 6, 271-281.
19. Yang X, Doser TA, Fang CX et al. (2006) Metallothionein prolongs survival and antagonizes senescence associated cardiomyocyte diastolic dysfunction: role of oxidative stress. FASEB J 20, 1024-1026.
20. Barsyte D, Lovejoy DA & Lithgow GJ (2001) Longevity and heavy metal resistance in daf-2 and age-1 long lived mutants of Caenorhabditis elegans. FASEB J 15, 627-634.
21. Feng W, Cai J, Pierce WM et al. (2005) Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. Biochem Biophys Res Commun 332, 853-858.
22. Cipriano C, Malavolta M, Costarelli L et al. (2006) Polymorphisms in MT1a gene with longevity in Italian central female population. Biogerontology 7, 357-365.
23. Yin X, Knecht DA & Lynes MA (2005) Metallothionein mediates leukocyte chemotaxis. BMC Immunol 6, 21-31.
24. Hujanen ES, Seppa ST & Virtanen K (1995) Polymorphonuclear leukocyte chemotaxis induced by zinc, copper and nickel in vitro. Biochim Biophys Acta 1245, 145-152.
25. Mocchegiani E, Giacconi R, Muti E et al. (2007) Zinc-bound metallothioneins and immune plasticity: lessons from very old mice and humans. Immun Ageing 4, 7-12.
26. Mocchegiani E, Giacconi R, Cipriano C et al. (2002) Metallothioneins (I + II) and thyroid-thymus axis efficiency in old mice: role of corticosterone and zinc supply. Mech Ageing Dev 123, 675-694.
27. Youn J & Lynes MA (1999) Metallothionein-induced suppression of cytotoxic T lymphocyte function: an important immunoregulatory control. Toxicol Sci 52, 199-208.
28. Lee WW, Cui D, Czesnikiewicz-Guzik M et al. (2008) Agedependent signature of metallothionein expression in primary CD4T cell responses is due to sustained zinc signaling. Rejuvenation Res 11, 1001-1011.
29. Malavolta M, Cipriano C, Costarelli L et al. (2008) Metallothionein downregulation in very old age: a phenomenon associated with cellular senescence? Rejuvenation Res 11, 455-459.
30. Feng W, Benz FW, Cai J et al. (2006) Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress. J Biol Chem 281, 681-687.
31. Zangger K, Oz G, Haslinger E et al. (2001) Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at inflammatory sites. FASEB J 15, 1303-1305.
32. 2+ release. Proc Natl Acad Sci USA 100, 13952-13957.
33. Malavolta M, Costarelli L, Giacconi R et al. (2006) Single and three-color flow cytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: relationship with metallothioneins. Cytometry A 69, 1043-1053.
34. Haase H, Hebel S, Engelhardt G et al. (2006) Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells. Anal Biochem 352, 222-230.
35. Giacconi R, Cipriano C, Muti E et al. (2005) Novel - 209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 6, 407-413.
36. Taylor KM, Vichova P, Jordan N et al. (2008) ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer cells. Endocrinology 149, 4912-4920.
37. Aydemir TB, Liuzzi JP, McClellan S et al. (2009) Zinc transporter ZIP8 (SLC39A8) and zinc influence IFN-{gamma} expression in activated human T cells. J Leukoc Biol 86, 337-348.
38. Haase H, Ober-Blobaum JL, Engelhardt G et al. (2008) Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J Immunol 181, 6491-6502.
39. Andree KB, Kim J, Kirschke CP et al. (2004) Investigation of lymphocyte gene expression for use as biomarkers for zinc status in humans. J Nutr 134, 1716-1723.
40. Mocchegiani E, Muzzioli M & Giacconi R (2000). Zinc, metallothioneins, immune responses, survival and ageing. Biogerontology 1, 133-143.
41. Haase H & Rink L (2007) Signal transduction in monocytes: the role of zinc ions. Biometals 20, 579-85.
42. Ostan R, Alberti S, Bucci L et al. (2006) Effect of zinc ions on apoptosis in PBMCs from healthy aged subjects. Biogerontology 7, 437-447.
43. Provinciali M, Di Stefano G & Stronati S (1998). Flow cytometric analysis of CD3/TCR complex, zinc, and glucocorticoid-mediated regulation of apoptosis and cell cycle distribution in thymocytes from old mice. Cytometry 32, 1-8.
44. Mann JJ & Fraker PJ (2005) Zinc pyrithione induces apoptosis and increases expression of Bim. Apoptosis 10, 369-379.
45. Iwata T, Incefy GS, Tanaka T et al. (1979) Circulating thymic hormone levels in zinc deficiency. Cell Immunol 47, 100-105.
46. Dardenne M, Boukaiba N, Gagnerault MC et al. (1993) Restoration of the thymus in aging mice by in vivo zinc supplementation. Clin Immunol Immunopathol 66, 127-135.
47. Wong CP, Song Y, Elias VD et al. (2009) Zinc supplementation increases zinc status and thymopoiesis in aged mice. J Nutr 139, 1393-1397.
48. Mocchegiani E, Giacconi R, Cipriano C et al. (2007) Zinc, metallothioneins, and longevity effect of zinc supplementation: zincage study. Ann NY Acad Sci 1119, 129-46.
49. Prasad AS, Fitzgerald JT, Hess JW et al. (1993) Zinc deficiency in elderly patients. Nutrition 9, 218-224.
50. Boukaiba N, Flament C, Acher S et al. (1993) A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population. Am J Clin Nutr 57, 566-572.
51. Bogden JD, Oleske JM, Lavenhar MA et al. (1990) Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly. J Am Coll Nutr 9, 214-25.
52. Cakman I, Kirchner H & Rink L (1997) Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J Interferon Cytokine Res 17, 469-472.
53. Fortes C, Forastiere F, Agabiti N et al. (1998) The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc 46, 19-26.
54. Hodkinson CF, Kelly M, Alexander HD et al. (2007) Effect of zinc supplementation on the immune status of healthy older individuals aged 55-70 years: the ZENITH Study. J Gerontol A Biol Sci Med Sci 62, 598-608.
55. Kahmann L, Uciechowski P, Warmuth S et al. (2008) Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res 11, 227-237.
56. Duchateau J, Delepesse G, Vrijens R et al. (1981) Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med 70, 1001-1004.
57. Sandstead HH, Henriksen LK, Greger JL et al. (1982) Zinc nutriture in the elderly in relation to taste acuity, immune response, and wound healing. Am J Clin Nutr 36, 1046-1059.
58. Cossack ZT (1989) T-lymphocyte dysfunction in the elderly associated with zinc deficiency and subnormal nucleoside phosphorylase activity: effect of zinc supplementation. Eur J Cancer Clin Oncol 25, 973-976.
59. Wagner PA, Jernigan JA, Bailey LB et al. (1983) Zinc nutriture and cell-mediated immunity in the aged. Int J Vitam Nutr Res 53, 94-101.
60. Prasad AS, Beck FW, Bao B et al. (2007) Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85, 837-844.
61. Bogden JD, Oleske JM, Lavenhar MA et al. (1988) Zinc and immunocompetence in elderly people: effects of zinc supplementation for 3 months. Am J Clin Nutr 48, 655-663.
62. Provinciali M, Montenovo A, Di Stefano G et al. (1998) Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial. Age Ageing 27, 715-722.
63. Stewart-Knox BJ, Simpson EE, Parr H et al. (2008) Taste acuity in response to zinc supplementation in older Europeans. Br J Nutr 99, 129-136.
64. Mocchegiani E, Muzzioli M, Giacconi R et al. (2003) Metallothioneins/ PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev 124, 459-468.
65. Sladek R, Rocheleau G, Rung J et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885.
66. Mocchegiani E, Giacconi R, Cipriano C et al. (2004) The variation during the circadian cycle of liver CD1dunrestricted NK1.1 + TCRγδ + cells lead to successful ageing. Role of metallothionein/IL-6/gp130/PARP-1 interplay in very old mice. Exp Gerontol 39, 775-788.
67. Miyaji C, Watanabe H, Toma H et al. (2000) Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol 61, 908-916.
68. Mocchegiani E, Giacconi R, Costarelli L et al. (2008) Zinc deficiency and IL-6-174G/C polymorphism in old people from different European countries: effect of zinc supplementation. ZINCAGE study. Exp Gerontol 43, 433-444.
69. Mariani E, Neri S, Cattini L et al. (2008) Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: Interactive influence of + 647 MT1a and - 174 IL-6 polymorphic alleles. Exp Gerontol 43, 462-471.
70. Mazzatti DJ, Malavolta M, White AJ et al. (2008) Effects of interleukin-6-174C/G and metallothionein 1A +647A/C single-nucleotide polymorphisms on zinc-regulated gene expression in ageing. Exp Gerontol 43, 423-432.